Why the study?
Do corticosteroids and immunosuppressive agents improve survival in patients with myocarditis?
Do corticosteroids and immunosuppressive agents improve survival in patients with myocarditis?
Answers are grounded in this paper and cite their sources.
Current evidence does not support a survival benefit for corticosteroids or immunosuppressive agents in the treatment of myocarditis.
Myocarditis is an uncommon cause of cardiac disease that can result in arrhythmia, congestive heart failure, and death. Myocardial injury in myocarditis is due in part to activated cellular and humoral immune components directed toward normal cardiac tissue. Although numerous therapies for myocarditis, including corticosteroids and immunosuppressive agents, have been applied in animal experiments and in human studies, none have demonstrated survival benefit over untreated controls. In many patients, myocarditis may spontaneously resolve. Information about myocarditis pathogenesis, manifestations, and treatment has been useful in disease management. Further research into the inflammatory nature of myocarditis may provide the basis for more favorable outcomes of intervention in this disease.
No takes yet. Share an insight, caveat, or question.
Olinde et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: